QTREX Quantum Ltd. (QTEX)
NASDAQ: QTEXHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
QTEX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $70.63M
- EPS (TTM)
- -$0.35
- Dividend yield
- None
- 52-week range
- 0.283 – 3.85
- Day range
- 0.9768 – 1.10
- Volume / Avg
- 2.89M / 9.21M
- Beta
- —
- Shares outstanding
- 70.63M
52-week range
QTEX stock today
Shares of QTREX Quantum (QTEX) finished lower on Nov 20 at $1.00, a drop of 10.71% or $0.12 per share, versus the S&P 500's 3.70% decline. Trading was light, with 2.89M shares changing hands, about 31% of the average daily volume. At this level, QTEX sits in the middle of its 52-week range of $0.283 to $3.85: 74.0% below the high, set on Jun 1, 2026 and 253.4% above the low.
QTEX is up 11.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 9.3%. QTREX Quantum has posted a net loss over the last twelve months (EPS of -$0.35), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About QTREX Quantum
Company profileQTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Dagi Shahar Ben-Noon
- Headquarters
- Ra'anana
- Employees
- 34
- IPO year
- 2021
- Website
- q-trex.com
Financial highlights
Full financialsIn fiscal 2025, QTREX Quantum generated $289,000 in revenue, up 0.0% from fiscal 2024. QTREX Quantum reported a net loss of $13.2 million, compared with a loss of $11.1 million a year earlier. Gross margin was 0.7% and operating margin -4713.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $289.00K | $0 | $0 | — | — |
| Growth | — | — | — | — | — |
| Net income | $-13.22M | $-11.05M | $-11.29M | $-14.98M | $-17.19M |
| EPS (diluted) | $-0.45 | $-0.60 | $-0.93 | $-1.39 | $-3.24 |
Analyst forecast
ForecastConsensus
none
Avg. price target
$5.00+400.00%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
QTEX news
All QTEX news- Inspira Technologies Oxy B.H.N. Ltd. Acquires Global Inkjet Systems for $16 millionNasdaq
- Inspira Technologies Oxy B.H.N. Ltd. Acquires Global Inkjet Systems for $16 millionNasdaq
- QTREX Acquires GIS to Scale Quantum Interconnect Production, Adding $10 Million in Cash and a Business with $11.3 Million in RevenueGlobeNewswire
- QTREX Quantum Reaffirms October 1 Disclosure and Expects Multiple Additional Commercial Agreements in the Fourth Quarter of 2026GlobeNewswire
- QTREX Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswire
- Correction: QTREX Quantum Announces Clean Capital StructureGlobeNewswire
- QTREX Quantum Announces Clean Capital StructureGlobeNewswire
QTREX Quantum peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LUCDLucid Diagnostics Inc. | 0.3727 | -3.52% | $72.57M | vs QTEX |
| SKINSkinHealth Systems Inc. Class A | 11.77 | -3.13% | $76.68M | vs QTEX |
| NYXHNyxoah SA | 0.805 | -7.01% | $81.98M | vs QTEX |
| LNSRLENSAR Inc. | 4.46 | -3.88% | $54.83M | vs QTEX |
| MBOTMicrobot Medical Inc. | 0.68 | -8.52% | $45.67M | vs QTEX |
| DXRDaxor Corporation | 7.45 | -7.33% | $43.49M | vs QTEX |
| APYXApyx Medical Corporation | 2.40 | +0.42% | $101.10M | vs QTEX |
| SRTSSensus Healthcare Inc. | 2.26 | -4.24% | $37.20M | vs QTEX |
Indexes, lists and sector
QTREX Quantum stock FAQ
What is QTREX Quantum's stock price today?
QTEX last traded at $1.00 as of Nov 20, 4:00 PM EST, down 10.71% on the day. Prices are delayed at least 15 minutes.
Who is QTREX Quantum's CEO?
Mr. Dagi Shahar Ben-Noon is the chief executive officer of QTREX Quantum Ltd., which has about 34 employees.
What is the QTEX 52-week high?
The 52-week high for QTEX is $3.85 and the 52-week low is $0.283. The stock is currently 74.0% below its high.